CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

NCT00327418 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2800

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Coronary Event
Cerebrovascular Accident
Coronary Artery Bypass Graft
Angina, Unstable
Revascularization

Interventions

DRUG: Atorvastatin

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]